You searched for Parkinson's - Page 12 of 20

News and Trends 30 May 2023

Pancreatic cancer microbiome discovery holds treatment hope

…neurological diseases such as Alzheimer’s disease and Parkinson’s disease. “Our bacteriophage-based new drug is undoubtedly a ‘first-in-concept’ drug that can effectively control various immune-related diseases. Therefore, we will continue to…

May 30, 2023 - 4 minutesmins - By Jim Cornall

Katharine dowson bioart science gallery hiv brain malformation glass

News and Trends 23 Apr 2016

BioArt : Katharine Dowson’s Brain Boxes, Crystal Chromosomes & HIV Vaccine Work

…in 2013 Katharine teamed up with the Medical Research Council UK to create sculptures of her own anatomy, including a life size glass heart, created from MRI scans. With Parkinson’s…

April 23, 2016 - 4 minutesmins - By Dani Bancroft

More News! 10 Dec 2024

Biotech in 2024: A retrospective

…adults with advanced Parkinson’s disease, providing a new approach to managing this neurodegenerative disorder. Hympavzi – Pfizer: In October 2024, the FDA approved Hympavzi for treating adults and adolescents with…

December 10, 2024 - 14 minutesmins - By Jules Adam

News and Trends 22 Feb 2017

Meet these 5 Awesome Biotechs from Barcelona at BIO Europe Spring 2017

…is being tested in 3 Phase I trials to treat dementia (including Alzheimer’s and Parkinson’s), multiple sclerosis and Huntington’s. Minoryx Therapeutics is committed to finding innovative treatments for life-threatening…

February 22, 2017 - 5 minutesmins - By External Contributor

gene therapy cell therapy advanced therapy 4BIO

News and Trends 9 Sep 2019

4BIO Capital Raises €45M Fund to Invest in Advanced Therapies

…accelerate the development of gene therapies for more common diseases, such as Parkinson’s disease. “We have a great opportunity to buck the trend,” Kuzmin said to me. “For the past…

September 9, 2019 - 3 minutesmins - By Jonathan Smith

huntingtons disease gene therapy uniqure2 1

News and Trends 23 Jan 2019

Update: The FDA Green-lights Clinical Trials for Huntington’s Disease Gene Therapy

…like Parkinson’s, so perhaps their technology could be transferred across. The use of gene therapy to correct a gene mutation that can have such devastating effects will be an effective…

January 23, 2019 - 3 minutesmins - By Alex Dale

News and Trends 17 May 2016

New Italian Drug is FDA approved for trials in Rare Neurological Disease

…Newron is a Biopharma developing therapies for diseases of the central nervous system (CNS). Last year it raised over €23M to advance its pipeline, which features candidates for Parkinson’s disease…

May 17, 2016 - 2 minutesmins - By Denise Neves Gameiro

Weekly Roundup 15 Dec 2023

Pharvaris’ $300 million public offering; Genentech’s breast cancer trial success; new neuromuscular disease target discovered

…that treat a range of neurological conditions like schizophrenia, Parkinson’s disease, and mood disorders, hence widening AbbVie’s existing neuroscience portfolio. This means that AbbVie will own the rights to Cerevel’s…

December 15, 2023 - 14 minutesmins - By Roohi Mariam Peter

Best in Biotech 30 Jan 2017

The Shiniest Golden Vertex? 15 Great Biotechs in Cambridge

…after. Although its platform for inhibitors of the deubiquitinating enzyme (DUB) it still in preclinical stage, Mission Therapeutic’s already has two candidates, USP30 and USP7, lined up to target Parkinson’s…

January 30, 2017 - 8 minutesmins - By Denise Neves Gameiro

Best in Biotech 26 Nov 2024

Seven miRNA-focused companies pioneering new therapies in 2024

…program, reporting broad biodistribution across the brain and effective target engagement. These results support the progression of BMD-001 toward formal clinical studies for Alzheimer’s disease, ALS, and Parkinson’s disease. Cardior…

November 26, 2024 - 9 minutesmins - By Jules Adam

News and Trends 18 Mar 2016

Biotech of the Week: Addex Therapeutics, a Swiss Biotech on a Rollercoaster ride

…company also announced the completion of the mGlu5 receptor occupancy study with dipraglurant with a healthy volunteer. Funded by the Michael J. Fox Foundation for Parkinson’s Research (MJFF), this trial…

March 18, 2016 - 2 minutesmins - By Joachim Eeckhout

Biotech deals partnerships and MA tracker

2024 biotech deals tracker: the latest partnerships and M&A

…November 2024: Vesalius, based in the United States, has partnered with GSK, based in the United Kingdom, to develop treatments for Parkinson’s disease. Vesalius is eligible to receive $80 million…

March 7, 2024 - 1 minutemin - By Aurore Michelin

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Parkinson's

Pancreatic cancer microbiome discovery holds treatment hope

BioArt : Katharine Dowson’s Brain Boxes, Crystal Chromosomes & HIV Vaccine Work

Biotech in 2024: A retrospective

Meet these 5 Awesome Biotechs from Barcelona at BIO Europe Spring 2017

4BIO Capital Raises €45M Fund to Invest in Advanced Therapies

Update: The FDA Green-lights Clinical Trials for Huntington’s Disease Gene Therapy

New Italian Drug is FDA approved for trials in Rare Neurological Disease

Pharvaris’ $300 million public offering; Genentech’s breast cancer trial success; new neuromuscular disease target discovered

The Shiniest Golden Vertex? 15 Great Biotechs in Cambridge

Seven miRNA-focused companies pioneering new therapies in 2024

Biotech of the Week: Addex Therapeutics, a Swiss Biotech on a Rollercoaster ride

2024 biotech deals tracker: the latest partnerships and M&A

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!